Adverse events in cancer genetic testing: Medical, ethical, legal, and financial implications

Cancer Journal (United States)

Volumn 18, Issue 4, 2012, Pages 303-309

  Brierley, Karina L ^a   Blouch, Erica ^b   Cogswell, Whitney ^c   Homer, Jeanne P ^d   Pencarinha, Debbie ^e   Stanislaw, Christine L ^f   Matloff, Ellen T ^a  

^a YALE CANCER CENTER   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c MEDICAL CENTER OF CENTRAL GEORGIA   (United States)

^d Hoag Hospital   (United States)

^e Kingsport Hematology and Oncology   (United States)

^f EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

BRCA1; BRCA2; cancer genetics; Genetic counseling; genetic testing; Lynch syndrome

Indexed keywords

BREAST CANCER; CANCER GENETICS; CANCER PREVENTION; CANCER SCREENING; DIAGNOSTIC ERROR; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HEALTH CARE COST; HUMAN; LABORATORY DIAGNOSIS; LAW SUIT; MEDICAL ERROR; MEDICAL ETHICS; MEDICAL LIABILITY; ONCOGENE; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; REVIEW;

DIAGNOSTIC ERRORS; FEMALE; GENETIC COUNSELING; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; LIABILITY, LEGAL; MEDICAL ERRORS; NEOPLASMS; RISK ASSESSMENT; UNNECESSARY PROCEDURES;

EID: 84864609013     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3182609490     Document Type: Review

References (43)

1. Guttmacher AE, Jenkins J, Uhlmann WR. Genomic medicine: who will practice it? A call to open arms. Am J Med Genet. 2001;106:216-222.
2. Greendale K, Pyeritz RE. Empowering primary care health professionals in medical genetics: How soon? How fast? How far? Am J Med Genet. 2001;106:223-232.
3. Brierley KL, Campfield D, Ducaine W, et al. Errors in delivery of cancer genetics services: Implications for practice. Conn Med. 2010;74: 413-423.
4. JaspersonKW, Burt RW. APC-associated polyposis conditions.Available at http://www.ncbi.nlm.nih.gov/books/NBK1345/. Accessed April 3, 2012.
5. Borry P, Stultiens L, Nys H, et al. Presymptomatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin Genet. 2006;70:374-381.
6. American Academy of Pediatrics: Committee on Bioethics. Ethical issues with genetic testing in pediatrics. Pediatrics. 2001;107:1451-1455.
7. Berliner JL, Fay AM. Risk assessment and genetic counseling for hereditary breast and ovarian cancer: Recommendations of the National Society of Genetic Counselors. J Genet Couns. 2007;16:241-260.
8. ASHG Board of Directors and ACMG Board of Directors. ASHG/ACMG report: Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet. 1995;57:1233-1241.
9. American Society of Clinical Oncology American Society of Clinical Oncology policy statement update: Genetic testing for cancer susceptibility. J Clin Oncol. 2003;21:2397-2406.
10. Reason J. Understanding adverse events: Human factors. Qual Health Care. 1995;4:80-89.
11. Mahlmeister LR. Human factors and error in perinatal care. J Perinat Neonatal Nurs. 2010;24:12-21.
12. Wilson RM, Harrison BT, Gibberd RW, et al. An analysis of the causes of adverse events from the Quality in Australian Health Care Study. Med J Aust. 1999;170:411-415.
13. Wideroff L,Vadaparampil ST, GreeneMH, et al. Hereditary breast/ovarian and colorectal cancer genetics knowledge in a national sample of US physicians. J Med Genet. 2005;42:749-755.
14. Doksum T, Bernhardt BA, Holtzman NA. Does knowledge about the genetics of breast cancer differ between nongeneticist physicians who do or do not discuss or order BRCA testing? Genet Med. 2003;5:99-105.
15. Domanska K, Carlsson C, Bendahl PO, et al. Knowledge about hereditary nonpolyposis colorectal cancer; mutation carriers and physicians at equal levels. BMC Med Genet. 2009;10:30.
16. Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: A systematic review of the literature. Genet Med. 2003;5:70-76.
17. Ready KJ, Daniels MS, Sun CC, et al. Obstetrics/gynecology residents' knowledge of hereditary breast and ovarian cancer and Lynch syndrome. J Cancer Educ. 2010;25:401-404.
18. Wilkins-Haug L, Hill L, et al. Gynecologists' training, knowledge, and experiences in genetics: A survey. Obstet Gynecol. 2000;95:421-424.
19. Thurston VC, Wales PS, Bell MA, et al. The current status of medical genetics instruction in U.S. and Canadian medical schools. Acad Med. 2007;82:441-445.
20. Riley BD, Culver JO, Skrzynia C, et al. Essential elements of genetic cancer risk assessment, counseling, and testing: Updated recommendations of the National Society of Genetic Counselors. J Genet Couns. 2012;21:151-161.
21. Commission on Cancer. Cancer Program Standards 2012 Ensuring Patient-Centered Care v.1.0. Available at: www.facs.org/cancer/coc/ cocprogramstandards2012.pdf. Accessed April 3, 2012.
22. Weeks WB, Wallace AE. Time and money: A retrospective evaluation of the inputs, outputs, efficiency, and incomes of physicians. Arch Intern Med. 2003;163:944-948.
23. Wood ME, Stockdale A, Flynn BS. Interviews with primary care physicians regarding taking and interpreting the cancer family history. Fam Pract. 2008;25:334-340.
24. Brandt R, Zonera A, Sabel A, et al. Cancer genetics evaluation: barriers to and improvements for referral. Genet Test. 2008;12:9-12.
25. Lowstuter KJ, Sand S, Blazer KR, et al. Influence of genetic discrimination perceptions and knowledge on cancer genetics referral practice among clinicians. Genet Med. 2008;10:691-698.
26. O'Neill SC, Peshkin BN, Luta G, et al. Primary care providers' willingness to recommend BRCA1/2 testing to adolescents. Fam Cancer. 2010;9:43-50.
27. Laedtke AL, O'Neill SM, RubinsteinWS, et al. Family physicians' awareness and knowledge of the Genetic Information Non-discrimination Act (GINA). J Genet Couns. 2012;21:345-352.
28. Swensen SJ, Kaplan GS, Meyer GS, et al. Controlling healthcare costs by removing waste: what American doctors can do now. BMJ Qual Saf. 2011;20:534-537.
29. Sherman D. Stemming overtreatment in U.S. healthcare may cut costs of care. Available at http://www.reuters.com/article/2012/02/16/us- healthovertreatment- idUSTRE81F15-20120216. Accessed April 3, 2012.
30. Bellcross CA, Kolor K, Goddard KAB, et al. Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians. Am J Prev Med. 2011;40:61-66.
31. Plon SE, Cooper HP, Parks B, et al. Genetic testing and cancer risk management recommendations by physicians for at-risk relatives. Genet Med. 2011;13:148-154.
32. Informed Medical Decisions. News: Aetna Press Release: Aetna to offer access to confidential telephonic cancer genetic counseling to health plan members. Available at: Http://www.informeddna.com/images/stories/news- articles/aetna%20press%20release%20bw.pdf. Accessed August 24, 2009.
33. Ray T. Lack of Physician Education, Genetic Counseling Could Ruin Value Proposition of PGx Testing, Insurer Says. Pharmacogenomics Reporter. Available at: Http://www.genomeweb.com/dxpgx/lack-physicianeducation- genetic-counseling- could-ruin-value-proposition-pgx-tes. Accessed August 24, 2009.
34. Ray T. United Healthcare issues prior notification requirement forMyriad's BRACAnalysis Test. Pharmacogenomics Reporter. Available at http://www.genomeweb.com/united-healthcare-issues-prior-notificationrequirement- myriads-bracanalysis-tes. Accessed April 3, 2012.
35. Ray T. Myriad defends policy of urging docs to genetically counsel BRACAnalysis customers. Pharmacogenomics Reporter. Available at http://www.genomeweb.com/dxpgx/myriad-defends-policy-urging-docsgenetically- counsel-bracanalysis-customers. Accessed April 3, 2012.
36. Lindor RA, Marchant GE, O'Connor SD. A review of medical malpractice claims related to clinical genetic testing.J ClinOncol. 2011;29(suppl); abstract 6073.
37. Miletich S, Armstrong K, Mayo J. Life-or-death question, but debatewas hidden for years. The Seattle Times. October 19, 2006. Available at: Http://community.seattletimes.nwsource.com/archive/?date=20061019& slug=virginiamason19m. Accessed April 3, 2012.
38. Lynch HT, Paulson J, Severin M, et al. Failure to diagnose hereditary colorectal cancer and its medicolegal implications: A hereditary nonpolyposis colorectal cancer case. Dis Colon Rectum. 1999;42:31-35.
39. Lubin IM, Caggana M, Constantin C, et al. Ordering molecular genetic tests and reporting results: Practices in laboratory and clinical settings. J Mol Diagn. 2008;10:459-468.
40. Raffan E, Semple RK. Next generation sequencing- implications for clinical practice. Br Med Bull. 2011;99:53-71.
41. Ku C-S, Cooper DN, Polychronakos C, et al. Exome sequencing: Dual role as a discovery and diagnostic tool. Ann Neurol. 2012;71:5-14.
42. Li C. Personalized medicineVthe promised land: Are we there yet? Clin Genet. 2011;79:403-412.
43. Gonzaga-Jauregui C, Lupski JR, Gibbs RA. Human genome sequencing in health and disease. Annu Rev Med. 2012;63:35-61.